Pfizer

company on 27 shows · 30 statements across 26 episodes · said 234 times in 107 episodes since 2013

All-In 118 Capital Allocators 13 the a16z Podcast 10 Acquired 9 My First Million 8 Top Founders 8 No Priors 7 Big Technology 7 Innovators & Investors 6 Latent Space 6 WTF is with Nikhil Kamath 6 the MAD Podcast 6 the Knowledge Project 5 TBPN 5 BigDeal 4 Invest Like the Best 3 the Y Combinator Startup Podcast 2 Lenny's Podcast 2 Founder's Journal 1 Startup Acquisition Stories 1 Cheeky Pint 1 the Neon Show 1 the Startup Ideas Podcast 1 Sourcery 1 Catalyst 1 How I Built This 1 20VC 1

Mentions by year, every show

tap a year for its mentions
003010602020132014201520162017201820192020202120222023202420252026episodesmentions
0102020132014201520162017201820192020202120222023202420252026episodes it came up in
0041082020132014201520162017201820192020202120222023202420252026episodesmentions per episode

All-In 118Capital Allocators 13the a16z Podcast 10Acquired 9Top Founders 8My First Million 8Big Technology 7No Priors 719 more shows

2026 24 mentions in 14 episodes 2 per episode
2025 18 mentions in 16 episodes 1 per episode
2024 25 mentions in 17 episodes 1 per episode
2023 48 mentions in 16 episodes 3 per episode
2022 19 mentions in 8 episodes 2 per episode
2021 52 mentions in 16 episodes 3 per episode
2020 25 mentions in 4 episodes 6 per episode
2019 7 mentions in 5 episodes 1 per episode
2018 4 mentions in 4 episodes 1 per episode
2017 6 mentions in 5 episodes 1 per episode
2016 5 mentions in 1 episode
2013 1 mention in 1 episode

every mention on every show, scene by scene, with the transcript →

30 statements about Pfizer, every show

LATENT SPACE Assertion Not checkable as stated
Beam: Lila's in vivo CAR-T data outperformed Capstan in non-human primates
“So we have developed some monster UTRs, untranslated regions, which flank the protein coding region which dictate those expression properties. Something like Tenex, the references from Moderna and Pfizer. And over the course of six months, got to in vivo data …”
Andy Beam Jul 16, 2026 ▶ 48:48 🔬 RL with Verifiable Rewards, but the Verifier is a Lab — Lila Sciences
WTF Assertion Supported
Prasad: Innovator drug production costs represent only 3% of the price
“See, the cost of production is not material during the patent time. Right. So they don't. Three percent, four percent.”
G. V. Prasad Jun 17, 2026 ▶ 28:19 Two Pharma Giants Who'd Never Met | Mankind & Dr. Reddy's | WTF is Pharma? · Nikhil Kamath
Doronichev: Scientific Papers Enable Startups to Bypass Biopharma Relationship Networks
“So I guess the lesson for fellow founders here, yes, you might be disadvantaged in terms of, you know, whether or not you play golf with the CEO of Pfizer and it might feel like it's impossible to penetrate this big pharma world. However, if your research matt…”
Andrey Doronichev Apr 14, 2026 ▶ 14:41 Driving Efficiency in Biotech Research with Andrey Doronichev of BIOPTIC | The Innovators & Investors Podcast
BIG TECHNOLOGY Prediction Not checkable as stated
Levie: Pfizer And Eli Lilly Won't Be Disrupted By Delayed AI Adoption
“Like if Pfizer or Eli Lilly took a little bit longer to adopt AI as a result of, you know, wanting to be more pragmatic, that'll be totally fine. They're not going to get disrupted. Like they have enough of market position. They have enough distribution. They …”
Aaron Levie Sep 18, 2025 ▶ 24:05 Are 95% of Businesses Really Getting No Return on AI Investment? — With Aaron Levie
BIG TECHNOLOGY Assertion Supported
Kantrowitz: Anthropic works with Pfizer, United Airlines, and AIG
“So they are working with companies and industries like travel, healthcare, financial services, insurance companies like Pfizer, United airlines, and AIG to implement this technology within their workflows. And it's not just coding.”
Alex Kantrowitz Aug 6, 2025 ▶ 16:27 Anthropic’s Potential, AI Video Gets Crazy, Market Bubble Approaching?
Bitar: 3x1 acquired Pfizer's Venezuelan assets at ~3.5x to 4x EBITDA
“And then we subsequently acquired the assets of Pfizer in Venezuela. And then we subsequently last year acquired local assets Of a company called Vivas Pharmaceuticals, and the multiples were all around there.”
Rodrigo Bitar Apr 28, 2025 ▶ 21:23 Rodrigo Bitar – Overlooked Opportunities in Latin America (EP.442)
BIG TECHNOLOGY Assertion Partly supported
Diamandis: Moderna and Pfizer mRNA vaccines cost two dollars each to make
“So our mRNA vaccines from Moderna or Pfizer were gene therapies and they cost two bucks each, right? They were sold for 20 bucks or whatever the case might be. So we know that you can mass produce gene therapies extraordinarily cheaply.”
Peter Diamandis Jul 29, 2024 ▶ 46:25 Peter Diamandis — Embracing AI, Befriending Elon, And Living Forever
BIG TECHNOLOGY Disclosure
Wood: AWS worked with EvolutionaryScale on generative AI drug discovery
“Pfizer or the work we've done with a startup called evolutionary scale to be able to use generative AI to be able to design entirely to entirely new molecules to design entirely new antibodies that are manufacturable that can go on and find new drug targets. L…”
Matt Wood Jul 10, 2024 ▶ 9:29 Amazon's Longterm AI Vision — With AWS VP Matt Wood
CAPITAL ALLOCATORS Assertion Partly supported
Vieth: Overhaul tracks high-value cargo for Apple, Dell, and Pfizer
“Their customers are, I think, high-value goods. So Apple, Dell, Microsoft, Pfizer, Bristol-Myers, some cold storage, where they're Tracking and monitoring the environment of this high value cargo from beginning point to end point.”
Mike Vieth Jan 25, 2024 ▶ 34:04 Chad Summe and Mike Veith – Corridor of Commerce at eGateway Capital (EP.364)
ALL-IN Assertion Partly supported
Sacks: Pfizer lost $140 billion in market capitalization in 2023
“Its market cap has lost one hundred and forty billion dollars in valuation in 2023.”
David Sacks Dec 29, 2023 ▶ 50:22 E159: The Bestie Awards! Recapping the best and worst of 2023
ALL-IN Opinion
Sacks: Pfizer suffers credibility crisis over vaccine transparency
“I would say that the company is also suffering from a credibility crisis by not leveling with the public about the efficacy and safety of their vaccines.”
David Sacks Dec 29, 2023 ▶ 50:55 E159: The Bestie Awards! Recapping the best and worst of 2023
Corre: Arbitrageurs should have maximized exposure to 2009 Pfizer and Merck deals
“This was true in 2009 when Pfizer was buying Wyeth and Merck was buying Shearing Plow. Both were trading at really, really attractive spreads, but you had to say, look, they're both pharma deals. If there's going to be an issue, there could be an issue with bo…”
Isaac Corre Oct 16, 2023 ▶ 20:58 Isaac Corre – Event-Driven Investing at Governors Lane (EP.344)
NO PRIORS Assertion Not checkable as stated
Kelly: Major biotech and pharma companies remain fully vertically integrated
“Where's the fast platforms? Like, where's all the horizontal stuff? Where's the operating systems? And it's like nowhere, like vertical integration, Merck, Pfizer, Bayer, Syngenta, like every one of these companies is like its own tech stack top to bottom, you…”
Jason Kelly Sep 28, 2023 ▶ 16:13 No Priors Ep. 34 | With Ginkgo Bioworks Co-Founder and CEO Jason Kelly
NO PRIORS Assertion Supported
Gil: Top four or five tech companies equal the entire biopharma market cap
“If you add up the top four or five tech companies, their market cap equals the entire industry for biopharma.”
Elad Gil Apr 27, 2023 ▶ 28:15 No Priors Ep. 14 | With Sarah Guo and Elad Gil
ALL-IN Assertion Supported
Friedberg estimates Pfizer making $10B-$15B from COVID vaccine in 2023
“I think they're making 10 to fifteen billion dollars on this vaccine this year.”
David Friedberg Jan 27, 2023 ▶ 43:17 E113: DOJ tries to break up Google, vaccine questions, Ukraine escalation & more
Acker: Janus Henderson invested in BioNTech in 2017 at $2B valuation
“BioNTech, which is the company that made the first MRNA vaccine along with Pfizer, we invest in that company when it was still a private company back in 2017 when most people had never heard of MRNA... Back then the company had a two billion market cap in 2021…”
Andy Acker Oct 6, 2022 ▶ 39:11 Andy Acker - Empty Rooms: Investing in Biotech at Janus Henderson (Capital Allocators, EP.274)
CAPITAL ALLOCATORS Assertion Supported
Acker: Pfizer needs to acquire $25 billion in revenue by 2030
“And even just Pfizer alone has said that they need to make acquisitions to acquire twenty five billion dollars of revenue by the end of 2030.”
Andy Acker Oct 6, 2022 ▶ 47:40 Andy Acker - Empty Rooms: Investing in Biotech at Janus Henderson (Capital Allocators, EP.274)
ACQUISITION STORIES Assertion Not checkable as stated
Kozinsky: Clinical Trial Startup Charged Pharma $10k–$20k Per Patient
“So it was a marketplace model, and our customers were like Pfizer and Novartis and Inovoderm, and they would pay us 10 to 20,000 dollars per patient to recruit a patient. We would split that with the doctor.”
Sieva Kozinsky Jul 19, 2022 ▶ 2:20 Startup Acquisition Stories with Sieva Kozinsky - Founder of Enduring Ventures
ACQUIRED Assertion Supported
Gassner: Pfizer was Veeva's first multi-million dollar annual contract
“The first multi-million dollar annual deals were a big customer, Pfizer, and, ah, it was just hand-to-hand combat.”
Peter Gassner May 19, 2022 ▶ 27:28 Capital-Efficient Growth (with Zoom CEO Eric Yuan & Veeva CEO Peter Gassner) · Acquired
ACQUIRED Assertion Not publicly verifiable
Gassner: Veeva funded early development via a $3M upfront Pfizer payment
“I thought, oh, we've just raised a three million dollar round of capital here and it didn't cost us any dilution, right? The check came in.”
Peter Gassner May 19, 2022 ▶ 29:07 Capital-Efficient Growth (with Zoom CEO Eric Yuan & Veeva CEO Peter Gassner) · Acquired
ALL-IN Prediction Not checkable as stated
Sachs: Oral COVID antiviral pills could end the pandemic in 2022
“These new pills have, I think, a very good shot of doing it next year because they're protease inhibitors, so they stop the virus From replicating, and just, and even if the spike proteins mutate, it will not prevent these protease inhibitors from working. So …”
David Sacks Dec 23, 2021 ▶ 37:10 E60: The 2021 Bestie Awards PLUS Jack Dorsey starts the Web3 Wars
FOUNDER'S JOURNAL Assertion Supported
Kirkland's 2020 revenue exceeded Nike, Coca-Cola, Pfizer, and Amex
“Kirkland, a private label brand, did more revenue last year than American Express, Pfizer, Coca-Cola, and Nike.”
Alex Lieberman Sep 17, 2021 ▶ 11:33 Costco's Secret Weapon
ALL-IN What-if
Sacks: Moderna vaccine would have released before election without trial delay
“If it weren't for those three weeks, Moderna's vaccine would have happened before Pfizer, and it would have come out about a week before the election.”
David Sacks Nov 25, 2020 ▶ 17:45 E13: SPACsgiving Special! Vaccine news, innovation vs regulation, fixing higher ed, challenge trials
ALL-IN What-if
Calacanis: Trump would have won if Pfizer news broke before election
“I believe if the Pfizer news comes out last week, Trump wins”
Jason Calacanis Nov 11, 2020 ▶ 5:15 E12: Biden wins, Pfizer vaccine, markets rip, Trump's next act, COVID endgame scenarios & more
ALL-IN Assertion Contradicted
Sacks: Pfizer delayed vaccine trial announcement to avoid influencing the election
“And so Pfizer had this news weeks ago. Now I understand their reason for not wanting to appear to be influencing the outcome of the election. So I, that's why they held onto it.”
David Sacks Nov 11, 2020 ▶ 16:52 E12: Biden wins, Pfizer vaccine, markets rip, Trump's next act, COVID endgame scenarios & more
a16z Insight
Bahcall: Ancient empires stifled innovation much like modern big pharma
“China, India, and the Islamic empires were a lot like the Merck, Pfizer, and Novartis of today. They were global, everywhere, dominant. They're phenomenal at franchises. So in India, you've had the Taj Mahal. You know, in China, they built the Great Wall and j…”
Safi Bahcall Apr 1, 2019 ▶ 4:20 a16z Podcast | Incenting Innovation Inside, Loonshots to Moonshots
a16z Assertion Partly supported
Hirasaki: Major biopharma companies faced critical patent cliffs in 2018
“Roche lost exclusivity on Zolaire and Rituxin. Pfizer lost exclusivity on Lyrica. And GSK lost exclusivity on Advair.”
Koki Hirasaki Feb 28, 2019 ▶ 1:30 What’s with All the Bio M&A in 2019?: A Quick Take
a16z Prediction Not checkable as stated
Pande: Digital health startups could be acquired by pharma or tech giants
“I could see a Pfizer buying Omada, you know, and maybe coupling with a drug or maybe not. I could see Google buying a company like Omada. I could see Freenome being bought either by a therapeutics company that wants a diagnostic, or by, let's say, a sequencing…”
Vijay Pande Jul 15, 2017 ▶ 9:31 On Machine Learning in Medicine and More
TOP FOUNDERS Disclosure
Skievaski says Redox would reject a $50M acquisition offer from pharma
“If Amgen or Pfizer offers you 40 or fifty million bucks for the company today, do you sell? No. From our perspective, well, well, and particularly because of those types of, you know, these are pharmaceutical companies. I don't think they're well suited to sol…”
Nico Skievaski Jun 8, 2017 ▶ 17:43 684: How to Raise Your First Round of Funding with Healthcare API, Redox Founder Niko Skievaski
Endowment investment committees should add operating CEOs alongside Wall Street professionals
“So I met with David a couple months back, and one of the interesting things he talked to me about with his investment committee was getting non-financial people involved on the committee. And I think there's huge value in that. Like, at Tufts, we have CEOs of …”
Steve Galbraith Apr 13, 2017 ▶ 1:11:53 Steven Galbraith – Five Tool Player (Capital Allocators, EP.01)

← every entity, every show

Made with StarZero

Turn any episode into a week of clips.

This entire site, thousands of episodes across every show transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.